AstraZeneca coronavirus vaccine reaches major hurdle: final US testing
The potential vaccine was invented by the University of Oxford and an associated company, Vaccitech. Meanwhile, a U.S. advisory panel is suggesting a way to ration the first limited doses once a vaccine does prove safe and effective.
The potential vaccine was invented by the University of Oxford and an associated company, Vaccitech. Meanwhile, a U.S. advisory panel is suggesting a way to ration the first limited doses once a vaccine does prove safe and effective.
Fad or future? Telehealth expansion eyed beyond COVID-19 pandemic
During the coronavirus pandemic the use of telehealth visits has taken off after Medicare temporarily relaxed restrictions that predated the smartphone era.
During the coronavirus pandemic the use of telehealth visits has taken off after Medicare temporarily relaxed restrictions that predated the smartphone era.
Coronavirus hits older men harder than women, study finds
Older men infected with the novel coronavirus are up to twice as likely to become severely sick and die as women of the same age, according to a study published Wednesday.
Older men infected with the novel coronavirus are up to twice as likely to become severely sick and die as women of the same age, according to a study published Wednesday.
WHO: Avoid dental cleanings and other routine visits to the dentist for now
You should put off routine dental care until coronavirus cases fall, according to the WHO. UPDATE: A network of dentists in the U.S. have pushed back.
You should put off routine dental care until coronavirus cases fall, according to the WHO. UPDATE: A network of dentists in the U.S. have pushed back.
U.N.: COVID-19 plasma treatment is still experimental
The World Health Organization is cautioning that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy.
The World Health Organization is cautioning that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy.
CDC: September, October are best months to get your flu shot
Infectious disease experts say that while there isn't a coronavirus vaccine yet, flu vaccinations are recommended for everyone over 6 months old.
Infectious disease experts say that while there isn't a coronavirus vaccine yet, flu vaccinations are recommended for everyone over 6 months old.
Johnson & Johnson set to begin crucial COVID-19 vaccine trial with 60,000 people
Janssen Pharmaceutical is planning to recruit about 60,000 participants to test its COVID-19 vaccine.
Janssen Pharmaceutical is planning to recruit about 60,000 participants to test its COVID-19 vaccine.
20% of US nursing homes faced severe PPE and staff shortages amid COVID-19 surges
Significantly, there was no improvement from May to July in the shortages of personal protective equipment, known as PPE, or in the staffing shortfalls, according to the analysis of federal data by academic researchers. The summer has seen the coronavirus surge across the South, and much of the West and Midwest.
Significantly, there was no improvement from May to July in the shortages of personal protective equipment, known as PPE, or in the staffing shortfalls, according to the analysis of federal data by academic researchers. The summer has seen the coronavirus surge across the South, and much of the West and Midwest.
'Hospital at home' programs taking off across country amid pandemic
As hospitals care for people with COVID-19 and try to keep others from catching the virus, more patients are opting to be treated where they feel safest: at home.
As hospitals care for people with COVID-19 and try to keep others from catching the virus, more patients are opting to be treated where they feel safest: at home.
FDA medical supply shortage list includes respirators, gloves, testing swabs
The FDA released a medical supply shortage list on the agency’s website, and the list features critical supplies in the fight against COVID-19, including testing swabs, certain respirators and hospital gowns.
The FDA released a medical supply shortage list on the agency’s website, and the list features critical supplies in the fight against COVID-19, including testing swabs, certain respirators and hospital gowns.
8-year-old boy tests an 'Iron Man' bionic arm for first time
James has a Hero Arm, which was custom made for him by Open Bionics.
James has a Hero Arm, which was custom made for him by Open Bionics.
US nursing home cases up nearly 80% in COVID-19 rebound
A new report says COVID-19 cases in U.S. nursing homes jumped nearly 80% earlier this summer, driven by rampant spread across the South and much of the West.
A new report says COVID-19 cases in U.S. nursing homes jumped nearly 80% earlier this summer, driven by rampant spread across the South and much of the West.
U.S. health insurers post huge profits during pandemic
U.S. health insurance companies posted massive second-quarter earnings as people postponed elective medical procedures during the coronavirus pandemic.
U.S. health insurance companies posted massive second-quarter earnings as people postponed elective medical procedures during the coronavirus pandemic.
Study hints, can't prove, survivor plasma fights COVID-19
Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they'll ever get a clear answer.
Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they'll ever get a clear answer.
Get tested once a month? Experts say NYC’s COVID-19 recommendations are unrealistic
Top health officials in New York City are urging people to get tested for coronavirus once a month, but other experts say such an idea isn't realistic.
Top health officials in New York City are urging people to get tested for coronavirus once a month, but other experts say such an idea isn't realistic.
Infectious disease experts say it may take 1 year for COVID-19 vaccine to be widely available after approval
According to a survey from InCrowd, a medical research company, a majority of infectious disease experts believed it would likely take as long as a year before a coronavirus vaccine is widely available to the public after the vaccine’s approval.
According to a survey from InCrowd, a medical research company, a majority of infectious disease experts believed it would likely take as long as a year before a coronavirus vaccine is widely available to the public after the vaccine’s approval.
Study: Majority of states facing shortage of ICU doctors
A new study says that twenty-six states across the nation are at risk of not having enough ICU doctors to treat COVID-19 patients.
A new study says that twenty-six states across the nation are at risk of not having enough ICU doctors to treat COVID-19 patients.
Companies test antibody drugs to help treat and prevent coronavirus ahead of a vaccine
It can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.
It can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.
Health officials across US are quitting or getting fired amid the COVID-19 pandemic
Dozens of state and local public health leaders around the country have resigned or have been fired amid the coronavirus outbreak.
Dozens of state and local public health leaders around the country have resigned or have been fired amid the coronavirus outbreak.
NIH seeks COVID-19 patient volunteers to test safety, longevity of synthetic antibody treatment
The trial, titled ACTIV-3, is asking for patients who are currently being treated for the novel coronavirus at select hospitals around the world, according to the NIH.
The trial, titled ACTIV-3, is asking for patients who are currently being treated for the novel coronavirus at select hospitals around the world, according to the NIH.